BDRX Kacepetan wutah bathi saben saham ing taun lumaku Biodexa Pharma

Lambang korporat lan logo Biodexa Pharmaceuticals (BDRX)

Biodexa Pharmaceuticals (BDRX) relies on the Q-Spheres ecosystem for targeted drug delivery. The company's key priority is developing treatments for rare brain tumors that can cross the blood-brain barrier. Patent protection and FDA standards create a significant barrier to entry for competitors. The YoY earnings per share growth rate on GURU.Markets illustrates a trend where 99.50 shows the current value of the metric.

BDRX - Wutah bathi ing taun lumaku biodexapharma.com ing rentang 28.04.2023 - 15.11.2026

Rincian metrik keuangan lan pasar Biodexa Pharmaceuticals PLC (BDRX)

- kuotasi saiki lan rata-rata prakiraan nilai:
Ringkesan analisis perusahaan:biodexapharma.com (BDRX)
Produk merek biodexapharma.com

This indicator serves as a key filter during asset stress testing, revealing the actual efficiency of profit generation. The metric measures the daily percentage deviation of current earnings per share from the same period last year, eliminating uncertainty between quarterly reports. By analyzing the annual EPS trend, an investor can assess the monetization potential of Biodexa Pharmaceuticals (BDRX) intellectual property through future royalties from global partners.